학술논문

A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
Document Type
Article
Source
In: Annals of Hematology. (Annals of Hematology, June 2021, 100(6):1497-1508)
Subject
Language
English
ISSN
14320584
09395555